Clinical nutrition is an area of medicine that offers treatment of medical disorders caused due to improper diet or due to the bodyinability to absorb nutrients available in a normal diet. Clinical nutrition products include clinical foods and dietary supplements that are categorized primarily as pharmaceuticals and are delivered through enteral and parenteral feeding for metabolic disorders, eating or nutritional disorders and other conditions.
Global Clinical Nutrition Market-Market Dynamics
The geriatric population with weak digestive systems constitutes a majority of the clinical nutrition market. There is also good demand for clinical foods in pediatrics.
The increase in number of diabetes cases diagnosed as a result of development in technology has helped in identifying and targeting a larger consumer base for various clinical nutrition products. This is a major driver for the US market. About 9.3% of the population, that is, 29.1 million people in the US, have diabetes, out of which 21 million people are diagnosed, while 8.1 million are undiagnosed. Some of the other drivers of the global clinical nutrition market are:
Growing aging population
Increasing incidence and diagnosis of diseases like cardiovascular diseases, cancer, dementia and diabetes
Increased preterm births in high-income countries
Increasing acceptance and adoption of infant and child nutrition as a result of changing lifestyle in the developing countries
The market is highly constrained due to strict FDA regulations and market volatility.
The global clinical nutrition market is composed of various market segments that contribute to the total market value. The global clinical nutrition market has been segmented based on various therapeutic areas where clinical nutrition is needed; various ingredients that are present in clinical nutrition products; the route of administration of these products and the end-user of the products. Further, each of these broad segments is divided into sub-segments. The therapeutic areas covered in this report are protein maldigestion, malabsorption, food allergies, diarrhea, cancer, diabetes, short-bowel syndrome, GI- tract impairment, acute lung injury, and acute respiratory distress. The segmentation based on ingredients includes amino acids, vitamins and minerals, carbohydrate and others. The segmentation based on the route of administration includes parenteral and enteral nutrition and lastly, the segmentation based on end-user includes application in infants, children, adults, and in the geriatric population.
One of the key findings of the study is that the enteral route of administration contributes a higher share of the market than the parenteral route of administration. This is mainly because only the patients with gut malfunctioning are fed by parenteral mode and rest all are fed by enteral modes of administration.
The global clinical nutrition market has also been geographically segmented into Asia-Pacific (China, India, Japan, Australia and others), Europe (Germany, UK, France, Italy, Spain, Scandinavia and Rest of Europe), North America (USA, Mexico and Canada), Middle East and North Africa (Egypt, GCC and Rest of MENA), Latin America (Brazil, Argentina, Colombia and others) and the Rest of the World.
Owing to the high prevalence and increasing incidence of chronic diseases, developing healthcare infrastructure, increasing awareness about clinical nutrition and rising income of the people, the market in Asia-Pacific is the largest in the world and it is expected that this trend will continue till 2021.
Market analysis for the clinical nutrition market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.
1.1 Report Description
1.2 Study Assumptions
1.3 Market Definitions
2. Research Approach and Methodology
2.2 Analysis Methodology
2.3 Study Phases
2.3.1 Secondary Research
2.3.2 Discussion Guide
2.3.3 Market Engineering & Econometric Model
2.3.4 Expert Validation
2.4 Study timeline
3. Executive Summary
4. Market Overview
4.1 Market Introduction
4.2 Market Dynamics
4.2.1 Market Drivers
126.96.36.199 Increasing availability of innovative products
188.8.131.52 Growing aging population
184.108.40.206 Increasing incidences of diseases requiring additional nutrients
4.2.2 Market Restraints
220.127.116.11 Volatility of Market
18.104.22.168 Stringent Regulatory Guidelines
4.2.3 Porter's five force analysis
22.214.171.124 Threat to new entrant
126.96.36.199 Internal Rivalry
188.8.131.52 Buyer Bargaining Power
184.108.40.206 Supplier Bargaining Power
220.127.116.11 Threats of substitutes
5. Market Segmentation
5.1 By Therapeutic Area
5.1.1 Protein Maldigestion
5.1.3 Food Allergies
5.1.7 Short- Bowel Syndrome
5.1.8 GI-Tract Impairment
5.1.9 Acute lung injury
5.1.10 Acute respiratory distress
5.2 By Ingredients
5.2.1 Amino Acids
5.3 By Route of administration
5.3.1 Parenteral Nutrition
5.3.2 Enteral Nutrition
5.4 By End-Users
5.5 By Geography
5.5.1 North America
18.104.22.168 United States
22.214.171.124 Spain & Portugal
126.96.36.199 Rest of Europe
188.8.131.52 Australia & New Zealand
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
5.5.4 Middle East and North Africa
18.104.22.168 Rest of Middle East and North Africa
5.5.5 Latin America
22.214.171.124 Rest of Latin America
6. Competitive Landscape
6.1 Merger and acquisition analysis
6.2 New Product Launches
6.3 Agreements, Collaborations, and Partnerships
7. Company Profiles
7.1 Abbott Healthcare
7.2 Nestle Health Sciences
7.3 Fresenius Kabi
7.4 Baxter Healthcare
7.5 B Braun Melsungen AG
7.7 Mead Johnson
7.8 H J Heinz Company
7.9 Perrigo Company PLC
8. Analyst Outlook for investment opportunity
9. Future outlook of the market